STOCK TITAN

Sale of 16,284 ABEO shares disclosed in Rule 144 notice

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of ABEO common stock has filed a notice of proposed sale under Rule 144 to sell 16,284 shares through broker Stifel Nicolaus & Company Inc. on or about February 2, 2026 on the Nasdaq, with an aggregate market value of $82,886.00.

The filing notes that 36,101 common shares were acquired on January 31, 2026 as restricted stock units from the issuer as equity compensation. The issuer had 54,191,361 shares of this class outstanding at the time referenced.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ABEO Form 144 filing disclose?

The filing discloses a planned sale of 16,284 shares of ABEO common stock under Rule 144. The shares are to be sold through Stifel Nicolaus & Company Inc. on or about February 2, 2026 on the Nasdaq exchange.

How many ABEO shares are planned to be sold and at what market value?

The notice covers a proposed sale of 16,284 common shares of ABEO with an indicated aggregate market value of $82,886.00. These figures give investors a sense of the transaction’s scale relative to overall trading and ownership levels.

How and when were the ABEO shares in this Form 144 acquired?

The filing states 36,101 ABEO common shares were acquired on January 31, 2026 as restricted stock units from the issuer, categorized as equity compensation. This indicates the securities originated from a compensation grant rather than an open-market purchase.

How many ABEO shares were outstanding for this class of stock?

For the class of common stock referenced in the filing, there were 54,191,361 shares outstanding. This figure provides a baseline for understanding how the planned sale of 16,284 shares compares with the issuer’s total common equity base.

Which broker and exchange are involved in the ABEO Rule 144 sale?

The planned sale will be executed through Stifel Nicolaus & Company Inc., located in St. Louis, Missouri. The securities are listed for trading on the Nasdaq exchange, where the 16,284 common shares are intended to be sold.

What type of ABEO security is being sold under this Form 144?

The security class identified is Common Stock of ABEO. The filing specifies a proposed sale of 16,284 common shares with an aggregate market value of $82,886.00, giving clarity on both the type and size of the planned transaction.
Abeona Therapeut

NASDAQ:ABEO

ABEO Rankings

ABEO Latest News

ABEO Latest SEC Filings

ABEO Stock Data

275.29M
47.79M
5.78%
73.58%
17.61%
Biotechnology
Pharmaceutical Preparations
Link
United States
CLEVELAND